BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31586530)

  • 1. Relation of Lipid-Lowering Therapy to Need for Aortic Valve Replacement in Patients With Asymptomatic Mild to Moderate Aortic Stenosis.
    Greve AM; Bang CN; Boman K; Egstrup K; Kesäniemi YA; Ray S; Pedersen TR; Wachtell K
    Am J Cardiol; 2019 Dec; 124(11):1736-1740. PubMed ID: 31586530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study).
    Greve AM; Bang CN; Boman K; Egstrup K; Forman JL; Kesäniemi YA; Ray S; Pedersen TR; Best P; Rajamannan NM; Wachtell K
    Am J Cardiol; 2018 Mar; 121(6):739-745. PubMed ID: 29361285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
    Rossebø AB; Pedersen TR; Boman K; Brudi P; Chambers JB; Egstrup K; Gerdts E; Gohlke-Bärwolf C; Holme I; Kesäniemi YA; Malbecq W; Nienaber CA; Ray S; Skjaerpe T; Wachtell K; Willenheimer R;
    N Engl J Med; 2008 Sep; 359(13):1343-56. PubMed ID: 18765433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Acceleration/Ejection Time Ratio Predicts Impaired Outcome in Aortic Valve Stenosis.
    Einarsen E; Cramariuc D; Bahlmann E; Midtbo H; Chambers JB; Gerdts E
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011467. PubMed ID: 33461302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.
    Rossebø AB; Pedersen TR; Allen C; Boman K; Chambers J; Egstrup K; Gerdts E; Gohlke-Bärwolf C; Holme I; Kesäniemi VA; Malbecq W; Nienaber C; Ray S; Skjaerpe T; Wachtell K; Willenheimer R
    Am J Cardiol; 2007 Apr; 99(7):970-3. PubMed ID: 17398194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).
    Bang CN; Greve AM; La Cour M; Boman K; Gohlke-Bärwolf C; Ray S; Pedersen T; Rossebø A; Okin PM; Devereux RB; Wachtell K
    Am J Cardiol; 2015 Dec; 116(12):1840-4. PubMed ID: 26602073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Dalsgaard M; Bang CN; Egstrup K; Ray S; Boman K; Rossebø AB; Gohlke-Baerwolf C; Devereux RB; Køber L; Wachtell K
    Stroke; 2014 Jul; 45(7):1939-46. PubMed ID: 24903982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial.
    Holme I; Boman K; Brudi P; Egstrup K; Gohlke-Baerwolf C; Kesäniemi YA; Malbecq W; Rossebø AB; Wachtell K; Willenheimer R; Pedersen TR
    Am J Cardiol; 2010 Jun; 105(12):1802-8. PubMed ID: 20538134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy.
    Hamilton-Craig I; Kostner K; Colquhoun D; Woodhouse S
    Heart Lung Circ; 2009 Oct; 18(5):343-6. PubMed ID: 19586799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of simvastatin and ezetimibe on suPAR levels and outcomes.
    Hodges GW; Bang CN; Forman JL; Olsen MH; Boman K; Ray S; Kesäniemi YA; Eugen-Olsen J; Greve AM; Jeppesen JL; Wachtell K
    Atherosclerosis; 2018 May; 272():129-136. PubMed ID: 29602140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis.
    Gerdts E; Rossebø AB; Pedersen TR; Cioffi G; Lønnebakken MT; Cramariuc D; Rogge BP; Devereux RB
    Circ Cardiovasc Imaging; 2015 Nov; 8(11):e003644; discussion e003644. PubMed ID: 26489804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study).
    Gerdts E; Rossebø AB; Pedersen TR; Boman K; Brudi P; Chambers JB; Egstrup K; Gohlke-Bärwolf C; Holme I; Kesäniemi YA; Malbecq W; Nienaber C; Ray S; Skjærpe T; Wachtell K; Willenheimer R
    Am J Cardiol; 2010 Dec; 106(11):1634-9. PubMed ID: 21094366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.
    Bang CN; Greve AM; Boman K; Egstrup K; Gohlke-Baerwolf C; Køber L; Nienaber CA; Ray S; Rossebø AB; Wachtell K
    Am Heart J; 2012 Apr; 163(4):690-6. PubMed ID: 22520536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events.
    Bang CN; Greve AM; Rossebø AB; Ray S; Egstrup K; Boman K; Nienaber C; Okin PM; Devereux RB; Wachtell K
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.
    Greve AM; Bang CN; Berg RM; Egstrup K; Rossebø AB; Boman K; Nienaber CA; Ray S; Gohlke-Baerwolf C; Nielsen OW; Okin PM; Devereux RB; Køber L; Wachtell K
    Int J Cardiol; 2015 Feb; 180():122-8. PubMed ID: 25438232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis.
    Lønnebakken MT; De Simone G; Saeed S; Boman K; Rossebø AB; Bahlmann E; Gohlke-Bärwolf C; Gerdts E
    Heart; 2017 Sep; 103(18):1443-1448. PubMed ID: 28455295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small aortic root in aortic valve stenosis: clinical characteristics and prognostic implications.
    Bahlmann E; Cramariuc D; Minners J; Lønnebakken MT; Ray S; Gohlke-Baerwolf C; Nienaber CA; Jander N; Seifert R; Chambers JB; Kuck KH; Gerdts E
    Eur Heart J Cardiovasc Imaging; 2017 Apr; 18(4):404-412. PubMed ID: 27491438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis.
    Losi MA; Mancusi C; Midtbø H; Saeed S; de Simone G; Gerdts E
    Int J Cardiol; 2019 Dec; 297():121-125. PubMed ID: 31604654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events.
    Rieck ÅE; Cramariuc D; Boman K; Gohlke-Bärwolf C; Staal EM; Lønnebakken MT; Rossebø AB; Gerdts E
    Hypertension; 2012 Jul; 60(1):90-7. PubMed ID: 22647889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis.
    Thomassen HK; Cioffi G; Gerdts E; Einarsen E; Midtbø HB; Mancusi C; Cramariuc D
    Heart; 2017 Oct; 103(20):1619-1624. PubMed ID: 28698175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.